Skip to main content
Erschienen in: Journal of Neurology 9/2009

01.09.2009 | Original Communication

Outcome in subgroups of mild cognitive impairment (MCI) is highly predictable using a simple algorithm

verfasst von: Joanna Mitchell, Robert Arnold, Kate Dawson, Peter J. Nestor, John R. Hodges

Erschienen in: Journal of Neurology | Ausgabe 9/2009

Einloggen, um Zugang zu erhalten

Abstract

Although it is well recognized that MCI represents a risk state for subsequent dementia, estimates of conversion vary widely according to the diagnostic criteria employed. There are currently no simple cognitive predictors of high and low risk of progression. We followed 107 non-demented non-depressed subjects from an original cohort of 124—sub-classified as follows: pure amnestic MCI (22), multi-domain MCI (54), non-amnestic MCI (10) and worried well (21). At 2 years, outcome varied considerably. Of the multi-domain MCI group 59% progressed to dementia and only 5% improved. By contrast, in pure amnestic MCI only 18% progressed and 41% improved. Of non-amnestic MCI patients 70% improved. The best predictor of progression was a combination of the Addenbrooke’s cognitive examination (ACE) and the paired associate learning task (PAL), which produced high negative predictive (90%) and sensitivity (94%) values. The results indicate very different outcomes according to whether patients have pure amnestic versus multi-domain MCI. While the latter is an aggressive disorder, the former is more benign and unstable even in a clinic setting. Patients with scores >88 on the ACE and/or <14 errors on the PAL can be confidently reassured of a good prognosis.
Literatur
1.
Zurück zum Zitat Albert MS, Moss MB, Tanzi R, Jones K (2001) Preclinical prediction of AD using neuropsychological tests. J Int Neuropsychol Soc 7:631–639PubMedCrossRef Albert MS, Moss MB, Tanzi R, Jones K (2001) Preclinical prediction of AD using neuropsychological tests. J Int Neuropsychol Soc 7:631–639PubMedCrossRef
2.
Zurück zum Zitat Alladi S, Arnold R, Mitchell J, Nestor PJ, Hodges JR (2006) Mild cognitive impairment: applicability of research criteria in a memory clinic and characterisation of cognitive profile. Psychol Med 36:507–515PubMedCrossRef Alladi S, Arnold R, Mitchell J, Nestor PJ, Hodges JR (2006) Mild cognitive impairment: applicability of research criteria in a memory clinic and characterisation of cognitive profile. Psychol Med 36:507–515PubMedCrossRef
3.
Zurück zum Zitat Bak TH, Rogers TT, Crawford LM, Hearn VC, Mathuranath PS, Hodges JR (2005) Cognitive bedside assessment in atypical parkinsonian syndromes. J Neurol Neurosurg Psychiatry 76:420–422PubMedCrossRef Bak TH, Rogers TT, Crawford LM, Hearn VC, Mathuranath PS, Hodges JR (2005) Cognitive bedside assessment in atypical parkinsonian syndromes. J Neurol Neurosurg Psychiatry 76:420–422PubMedCrossRef
4.
Zurück zum Zitat Blackwell AD, Sahakian BJ, Vesey R, Semple JM, Robbins TW, Hodges JR (2004) Detecting dementia: novel neuropsychological markers of pre-clinical Alzheimer’s disease. Dement Geriatr Cogn Disord 17:42–48PubMedCrossRef Blackwell AD, Sahakian BJ, Vesey R, Semple JM, Robbins TW, Hodges JR (2004) Detecting dementia: novel neuropsychological markers of pre-clinical Alzheimer’s disease. Dement Geriatr Cogn Disord 17:42–48PubMedCrossRef
5.
Zurück zum Zitat Bowen J, Teri L, Kukull W, McCormick W, McCurry SM, Larson EB (1997) Progression to dementia in patients with isolated memory loss. Lancet 349:763–765PubMedCrossRef Bowen J, Teri L, Kukull W, McCormick W, McCurry SM, Larson EB (1997) Progression to dementia in patients with isolated memory loss. Lancet 349:763–765PubMedCrossRef
6.
Zurück zum Zitat Bozoki A, Giordani B, Heidebrink JL, Berent S, Foster NL (2001) Mild cognitive impairments predict dementia in nondemented elderly patients with memory loss. Arch Neurol 58:411–416PubMedCrossRef Bozoki A, Giordani B, Heidebrink JL, Berent S, Foster NL (2001) Mild cognitive impairments predict dementia in nondemented elderly patients with memory loss. Arch Neurol 58:411–416PubMedCrossRef
7.
Zurück zum Zitat Brys M, Pirraglia E, Rich K, Rolstad S, Mosconi L, Switalski R, Glodzik-Sobanska L, De Santi S, Zinkowski R, Mehta P, Pratico D, Saint Louis LA, Wallin A, Blennow K, de Leon MJ (2009) Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment. Neurobiol Aging 30(5):682–690 Brys M, Pirraglia E, Rich K, Rolstad S, Mosconi L, Switalski R, Glodzik-Sobanska L, De Santi S, Zinkowski R, Mehta P, Pratico D, Saint Louis LA, Wallin A, Blennow K, de Leon MJ (2009) Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment. Neurobiol Aging 30(5):682–690
8.
Zurück zum Zitat Collie A, Maruff P (2000) The neuropsychology of preclinical Alzheimer’s disease and mild cognitive impairment. Neurosci Biobehav Rev 24(3):365–374PubMedCrossRef Collie A, Maruff P (2000) The neuropsychology of preclinical Alzheimer’s disease and mild cognitive impairment. Neurosci Biobehav Rev 24(3):365–374PubMedCrossRef
9.
Zurück zum Zitat De Jager CA, Hogervorst E, Combrinck M, Budge MM (2003) Sensitivity and specificity of neuropsychological tests for mild cognitive impairment, vascular cognitive impairment and Alzheimer’s disease. Psychol Med 33:1039–1050PubMedCrossRef De Jager CA, Hogervorst E, Combrinck M, Budge MM (2003) Sensitivity and specificity of neuropsychological tests for mild cognitive impairment, vascular cognitive impairment and Alzheimer’s disease. Psychol Med 33:1039–1050PubMedCrossRef
10.
Zurück zum Zitat de Leon MJ, Mosconi L, Blennow K, DeSanti S, Zinkowski R, Mehta PD, Pratico D, Tsui W, Saint Louis LA, Sobanska L, Brys M, Li Y, Rich K, Rinne J, Rusinek H (2007) Imaging and CSF studies in the preclinical diagnosis of Alzheimer’s disease. Ann N Y Acad Sci 1097:114–145PubMedCrossRef de Leon MJ, Mosconi L, Blennow K, DeSanti S, Zinkowski R, Mehta PD, Pratico D, Tsui W, Saint Louis LA, Sobanska L, Brys M, Li Y, Rich K, Rinne J, Rusinek H (2007) Imaging and CSF studies in the preclinical diagnosis of Alzheimer’s disease. Ann N Y Acad Sci 1097:114–145PubMedCrossRef
11.
Zurück zum Zitat Devanand DP, Folz M, Gorlyn M, Moeller JR, Stern Y (1997) Questionable dementia: clinical course and predictors of outcome. J Am Geriatr Soc 45:321–328PubMed Devanand DP, Folz M, Gorlyn M, Moeller JR, Stern Y (1997) Questionable dementia: clinical course and predictors of outcome. J Am Geriatr Soc 45:321–328PubMed
12.
Zurück zum Zitat Dudas RB, Berrios GE, Hodges JR (2005) The Addenbrooke’s cognitive examination (ACE) in the differential diagnosis of early organic dementias from affective disorder. Am J Geriatr Psychiatry 13:218–226PubMed Dudas RB, Berrios GE, Hodges JR (2005) The Addenbrooke’s cognitive examination (ACE) in the differential diagnosis of early organic dementias from affective disorder. Am J Geriatr Psychiatry 13:218–226PubMed
13.
Zurück zum Zitat Fischer PJS, Zehetmayer S, Weissgram S, Hoenigschnabl S, Gelpi E, Krampla W, Tragl KH (2007) Conversion from subtypes of mild cognitive impairment to Alzheimer dementia. Neurology 68:288–291PubMedCrossRef Fischer PJS, Zehetmayer S, Weissgram S, Hoenigschnabl S, Gelpi E, Krampla W, Tragl KH (2007) Conversion from subtypes of mild cognitive impairment to Alzheimer dementia. Neurology 68:288–291PubMedCrossRef
14.
Zurück zum Zitat Flicker C, Ferris SH, Reisberg B (1991) Mild cognitive impairment in the elderly: predictors of dementia. Neurology 41:1006–1009PubMed Flicker C, Ferris SH, Reisberg B (1991) Mild cognitive impairment in the elderly: predictors of dementia. Neurology 41:1006–1009PubMed
15.
Zurück zum Zitat Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198PubMedCrossRef Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198PubMedCrossRef
16.
Zurück zum Zitat Galton CJ, Erzinclioglu S, Sahakian BJ, Antoun N, Hodges JR (2005) A comparison of the Addenbrooke’s cognitive examination (ACE) conventional neuropsychological assessment and simple MRI-based medial temporal lobe evaluation in the early diagnosis of Alzheimer’s disease. Cogn Behav Neurol 18(3):144–150PubMedCrossRef Galton CJ, Erzinclioglu S, Sahakian BJ, Antoun N, Hodges JR (2005) A comparison of the Addenbrooke’s cognitive examination (ACE) conventional neuropsychological assessment and simple MRI-based medial temporal lobe evaluation in the early diagnosis of Alzheimer’s disease. Cogn Behav Neurol 18(3):144–150PubMedCrossRef
17.
Zurück zum Zitat Geslani DM, Tierney MC, Herrmann N, Szalai JP (2005) Mild cognitive impairment: an operational definition and its conversion rate to Alzheimer’s disease. Dement Geriatr Cogn Disord 19:383–389PubMedCrossRef Geslani DM, Tierney MC, Herrmann N, Szalai JP (2005) Mild cognitive impairment: an operational definition and its conversion rate to Alzheimer’s disease. Dement Geriatr Cogn Disord 19:383–389PubMedCrossRef
18.
Zurück zum Zitat Griffith HR, Martin RC, Bambara JK, Marson DC, Faught E (2006) Older adults with epilepsy demonstrate cognitive impairments compared with patients with amnestic mild cognitive impairment. Epilepsy Behav 8:161–168PubMedCrossRef Griffith HR, Martin RC, Bambara JK, Marson DC, Faught E (2006) Older adults with epilepsy demonstrate cognitive impairments compared with patients with amnestic mild cognitive impairment. Epilepsy Behav 8:161–168PubMedCrossRef
19.
Zurück zum Zitat Grundman M, Petersen RC, Ferris SH, Thomas RG, Aisen PS, Bennett DA, Foster NL, Jack CRJ, Galasko DR, Doody RS, Kaye J, Sano M, Mohs R, Gauthier S, Kim HT, Jin S, Schultz AN, Schafer K, Mulnard R, van Dyck CH, Mintzer J, Zamrini EY, Cahn-Weiner D, Thal LJ (2004) Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol 61:59–66PubMedCrossRef Grundman M, Petersen RC, Ferris SH, Thomas RG, Aisen PS, Bennett DA, Foster NL, Jack CRJ, Galasko DR, Doody RS, Kaye J, Sano M, Mohs R, Gauthier S, Kim HT, Jin S, Schultz AN, Schafer K, Mulnard R, van Dyck CH, Mintzer J, Zamrini EY, Cahn-Weiner D, Thal LJ (2004) Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol 61:59–66PubMedCrossRef
20.
Zurück zum Zitat Hodges JR, Erzinclioglu S, Patterson K (2006) Evolution of cognitive deficits and conversion to dementia in patients with mild cognitive impairment: a very long-term follow-up study. Dement Geriatr Cogn Disord 21:380–391PubMedCrossRef Hodges JR, Erzinclioglu S, Patterson K (2006) Evolution of cognitive deficits and conversion to dementia in patients with mild cognitive impairment: a very long-term follow-up study. Dement Geriatr Cogn Disord 21:380–391PubMedCrossRef
21.
Zurück zum Zitat Lehrner J, Gufler R, Guttmann G, Maly J, Gleiss A, Auff E, Dal-Bianco P (2005) Annual conversion to alzheimer disease among patients with memory complaints attending an outpatient memory clinic: the influence of amnestic mild cognitive impairment and the predictive value of neuropsychological testing. Wien Klin Wochenschr 117:629–635PubMedCrossRef Lehrner J, Gufler R, Guttmann G, Maly J, Gleiss A, Auff E, Dal-Bianco P (2005) Annual conversion to alzheimer disease among patients with memory complaints attending an outpatient memory clinic: the influence of amnestic mild cognitive impairment and the predictive value of neuropsychological testing. Wien Klin Wochenschr 117:629–635PubMedCrossRef
22.
Zurück zum Zitat Maioli F, Coveri M, Pagni P, Chiandetti C, Marchetti C, Ciarrocchi R, Ruggero C, Nativio V, Onesti A, D’Anastasio C, Pedone V (2007) Conversion of mild cognitive impairment to dementia in elderly subjects: a preliminary study in a memory and cognitive disorder unit. Arch Gerontol Geriatr 44(Suppl 1):233–241PubMedCrossRef Maioli F, Coveri M, Pagni P, Chiandetti C, Marchetti C, Ciarrocchi R, Ruggero C, Nativio V, Onesti A, D’Anastasio C, Pedone V (2007) Conversion of mild cognitive impairment to dementia in elderly subjects: a preliminary study in a memory and cognitive disorder unit. Arch Gerontol Geriatr 44(Suppl 1):233–241PubMedCrossRef
23.
Zurück zum Zitat Marcos A, Gil P, Barabash A, Rodriguez R, Encinas M, Fernandez C, Cabranes JA (2006) Neuropsychological markers of progression from mild cognitive impairment to Alzheimer’s disease. Am J Alzheimers Dis Other Demen 21:189–196PubMedCrossRef Marcos A, Gil P, Barabash A, Rodriguez R, Encinas M, Fernandez C, Cabranes JA (2006) Neuropsychological markers of progression from mild cognitive impairment to Alzheimer’s disease. Am J Alzheimers Dis Other Demen 21:189–196PubMedCrossRef
24.
Zurück zum Zitat Mathuranath PS, Nestor P, Berrios GE, Rakowicz W, Hodges JR (2000) A brief cognitive test battery to differentiate Alzheimer’s disease and frontotemporal dementia. Neurology 55:1613–1620PubMed Mathuranath PS, Nestor P, Berrios GE, Rakowicz W, Hodges JR (2000) A brief cognitive test battery to differentiate Alzheimer’s disease and frontotemporal dementia. Neurology 55:1613–1620PubMed
25.
Zurück zum Zitat McKenna P, Warrington EK (1983) Graded naming test. NFER-Nelson, Windsor McKenna P, Warrington EK (1983) Graded naming test. NFER-Nelson, Windsor
26.
Zurück zum Zitat Morris JC (1993) The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 43:2412–2414PubMed Morris JC (1993) The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 43:2412–2414PubMed
27.
Zurück zum Zitat Nestor PJ, Scheltens P, Hodges JR (2004) Advances in the early detection of Alzheimer’s disease. Nat Med 10(Suppl):S34–S41PubMedCrossRef Nestor PJ, Scheltens P, Hodges JR (2004) Advances in the early detection of Alzheimer’s disease. Nat Med 10(Suppl):S34–S41PubMedCrossRef
28.
Zurück zum Zitat Perry RJ, Hodges J (2003) Attentional control and the time course of attention in mild cognitive impairment measurement of attentional dwell time. Eur J Neurosci 18:221–226PubMedCrossRef Perry RJ, Hodges J (2003) Attentional control and the time course of attention in mild cognitive impairment measurement of attentional dwell time. Eur J Neurosci 18:221–226PubMedCrossRef
29.
Zurück zum Zitat Perry RJ, Watson P, Hodges JR (2000) The nature and staging of attention dysfunction in early (minimal and mild) Alzheimer’s disease: relationship to episodic and semantic memory impairment. Neuropsychologia 38:252–271PubMedCrossRef Perry RJ, Watson P, Hodges JR (2000) The nature and staging of attention dysfunction in early (minimal and mild) Alzheimer’s disease: relationship to episodic and semantic memory impairment. Neuropsychologia 38:252–271PubMedCrossRef
30.
Zurück zum Zitat Petersen RC (2004) Mild cognitive impairment as a diagnostic entity. J Intern Med 256:183–194PubMedCrossRef Petersen RC (2004) Mild cognitive impairment as a diagnostic entity. J Intern Med 256:183–194PubMedCrossRef
31.
Zurück zum Zitat Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, Ritchie K, Rossor M, Thal L, Winblad B (2001) Current concepts in mild cognitive impairment. Arch Neurol 58(12):1985–1992PubMedCrossRef Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, Ritchie K, Rossor M, Thal L, Winblad B (2001) Current concepts in mild cognitive impairment. Arch Neurol 58(12):1985–1992PubMedCrossRef
32.
Zurück zum Zitat Petersen RC, Smith GE, Waring SC, Ivnik RJ, Kokmen E, Tangelos EG (1997) Aging, memory, and mild cognitive impairment. Int Psychogeriatr 9(Suppl 1):65–69PubMedCrossRef Petersen RC, Smith GE, Waring SC, Ivnik RJ, Kokmen E, Tangelos EG (1997) Aging, memory, and mild cognitive impairment. Int Psychogeriatr 9(Suppl 1):65–69PubMedCrossRef
33.
Zurück zum Zitat Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56:303–308PubMedCrossRef Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56:303–308PubMedCrossRef
34.
Zurück zum Zitat Reitan RM (1985) Halstead-Reitan neuropsychological test battery. Reitan Neuropsychology Laboratory/Press, Tuscon Reitan RM (1985) Halstead-Reitan neuropsychological test battery. Reitan Neuropsychology Laboratory/Press, Tuscon
35.
Zurück zum Zitat Rey A (1941) L’examen psychologique dans les cas d’encephalopathie traumatique. Arch Psychol 28:286–340 Rey A (1941) L’examen psychologique dans les cas d’encephalopathie traumatique. Arch Psychol 28:286–340
36.
Zurück zum Zitat Rozzini L, Chilovi BV, Conti M, Bertoletti E, Delrio I, Trabucchi M, Padovani A (2007) Conversion of amnestic mild cognitive impairment to dementia of Alzheimer type is independent to memory deterioration. Int J Geriatr Psychiatry 22:1217–1222PubMedCrossRef Rozzini L, Chilovi BV, Conti M, Bertoletti E, Delrio I, Trabucchi M, Padovani A (2007) Conversion of amnestic mild cognitive impairment to dementia of Alzheimer type is independent to memory deterioration. Int J Geriatr Psychiatry 22:1217–1222PubMedCrossRef
37.
Zurück zum Zitat Schmidt M (1996) Rey auditory verbal learning test: a handbook. Western Psychological Services, Los Angeles Schmidt M (1996) Rey auditory verbal learning test: a handbook. Western Psychological Services, Los Angeles
38.
Zurück zum Zitat Snaith RP, Zigmund AS (1994) The hospital anxiety and depression scale. NFER Nelson, Windsor, UK Snaith RP, Zigmund AS (1994) The hospital anxiety and depression scale. NFER Nelson, Windsor, UK
39.
Zurück zum Zitat Swainson R, Hodges JR, Galton CJ, Semple J, Michael A, Dunn BD, Iddon JL, Robbins TW, Sahakian BJ (2001) Early detection and differential diagnosis of Alzheimer’s disease and depression with neuropsychological tasks. Dement Geriatr Cogn Disord 12:265–280PubMedCrossRef Swainson R, Hodges JR, Galton CJ, Semple J, Michael A, Dunn BD, Iddon JL, Robbins TW, Sahakian BJ (2001) Early detection and differential diagnosis of Alzheimer’s disease and depression with neuropsychological tasks. Dement Geriatr Cogn Disord 12:265–280PubMedCrossRef
40.
Zurück zum Zitat Tabert MH, Manly JJ, Liu X, Pelton GH, Rosenblum S, Jacobs M, Zamora D, Goodkind M, Bell K, Stern Y, Devanand DP (2006) Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment. Arch Gen Psychiatry 63:916–924PubMedCrossRef Tabert MH, Manly JJ, Liu X, Pelton GH, Rosenblum S, Jacobs M, Zamora D, Goodkind M, Bell K, Stern Y, Devanand DP (2006) Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment. Arch Gen Psychiatry 63:916–924PubMedCrossRef
41.
Zurück zum Zitat Tierney MC, Szalai JP, Snow WG, Fisher RH, Nores A, Nadon G, Dunn E, St George Hyslop PH (1996) Prediction of probable Alzheimer’s disease in memory-impaired patients – a prospective longitudinal study. Neurology 46:661–665PubMed Tierney MC, Szalai JP, Snow WG, Fisher RH, Nores A, Nadon G, Dunn E, St George Hyslop PH (1996) Prediction of probable Alzheimer’s disease in memory-impaired patients – a prospective longitudinal study. Neurology 46:661–665PubMed
42.
Zurück zum Zitat Welsh KA, Butters N, Hughes JP, Mohs RC, Heyman A (1992) Detection and staging of dementia in Alzheimer’s disease: use of the neuropsychological measures developed for the consortium to establish a registry for Alzheimer’s disease. Arch Neurol 49:448–452PubMed Welsh KA, Butters N, Hughes JP, Mohs RC, Heyman A (1992) Detection and staging of dementia in Alzheimer’s disease: use of the neuropsychological measures developed for the consortium to establish a registry for Alzheimer’s disease. Arch Neurol 49:448–452PubMed
43.
Zurück zum Zitat Whitwell JL, Jack CR Jr, Baker M, Rademakers R, Adamson J, Boeve BF, Knopman DS, Parisi JF, Petersen RC, Dickson DW, Hutton ML, Josephs KA (2007) Voxel-based morphometry in frontotemporal lobar degeneration with ubiquitin-positive inclusions with and without progranulin mutations. Arch Neurol 64:371–376PubMedCrossRef Whitwell JL, Jack CR Jr, Baker M, Rademakers R, Adamson J, Boeve BF, Knopman DS, Parisi JF, Petersen RC, Dickson DW, Hutton ML, Josephs KA (2007) Voxel-based morphometry in frontotemporal lobar degeneration with ubiquitin-positive inclusions with and without progranulin mutations. Arch Neurol 64:371–376PubMedCrossRef
44.
Zurück zum Zitat Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Backman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, DeCarli C, Erkinjuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, van Duijn C, Visser P, Petersen RC (2004) Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 256:240–246PubMedCrossRef Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Backman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, DeCarli C, Erkinjuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, van Duijn C, Visser P, Petersen RC (2004) Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 256:240–246PubMedCrossRef
Metadaten
Titel
Outcome in subgroups of mild cognitive impairment (MCI) is highly predictable using a simple algorithm
verfasst von
Joanna Mitchell
Robert Arnold
Kate Dawson
Peter J. Nestor
John R. Hodges
Publikationsdatum
01.09.2009
Verlag
D. Steinkopff-Verlag
Erschienen in
Journal of Neurology / Ausgabe 9/2009
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-009-5152-0

Weitere Artikel der Ausgabe 9/2009

Journal of Neurology 9/2009 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.